An observational study in Mental Health and Cancer, sponsored by European Institute of Oncology. Recruiting at 1 site in Italy. Per ClinicalTrials.gov, last updated 2026-09-10.
Sponsored by European Institute of Oncology · Observational
To develop and administer online surveys to cancer patients and their families across diverse regions within the EU to detect possible disparities in their access to mental health screening and psychological-cognitive support
In order to detect possible disparities in the access to mental health screening and psychological-cognitive support, cancer patients and survivors will be involved. A minimum of 1000 patients will be surveyed to gather insights on their experiences with mental health screening, the support they received, and perceived barriers and facilitators in accessing mental health services. Similarly, caregivers and/or family members of cancer patients will be invited to participate in this study. At least 1000 family members and caregivers who support cancer patients will also be surveyed to understand their mental health needs and the challenges they encounter in seeking support for themselves and for patients. For these surveys, individuals at all cancer stages who have been diagnosed with cancer, are currently undergoing treatment or have survived cancer will be invited to participate. Participants must reside in the EU, have Internet access and can use a technological device for survey participation.
Considering the pediatric population, the following inclusion criteria will be adopted:
Regarding caregivers and family members, the investigators will include individuals that are aged 18 or older who currently provide, or have provided, care, psychosocial and physical support for a cancer patient in the EU. As with patients, caregivers and family members should also have access to the internet and at least one technological device.
10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 200 across 2,638 observational studies indexed under Neoplasms.
Browse Neoplasms studies →European Institute of Oncology is the lead sponsor of 185 studies on the registry; 118 are open to participants now.
Compared within Neoplasms, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Cancer patients (both adult and paediatric) and their family members\caregivers living in EU.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Inclusion Criteria for family members and caregivers:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Individuals aged 18 years or older at all cancer stages, who have been diagnosed with cancer, are currently undergoing treatment or have survived cancer
individuals that are aged 18 or older who currently provide, or have provided, care, psychosocial and physical support for an adult cancer patient
Pediatric cancer patients 12-17 years, responding on behalf of themselves
Family members and caregivers of patients between 0-11 years old, responding on behalf of their child and themselves
Family members and caregivers of patients between 12-17 years old responding only on behalf of themselves
Disparities in access to mental health
Number of participants who experienced disparities in the access to and provision of mental health services, how frequently EU countries have encountered these disparities, and detection of the principal barriers and facilitators through thematic analysis
Time frame: through study completion, an average of 1 year
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Oct 2026, 1 month after the start.
Of 1,098 non-industry observational studies under Neoplasms, half reached primary completion within 61 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 227. This study's planned 1 month is below that.
Counting every sponsor, half of 1,246 studies reached it within 58 months; a quarter within 24 and three quarters within 210.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
European Institute of Oncology →